{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T20:10:24Z","timestamp":1794600624281,"version":"4.9.1"},"reference-count":97,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jaccao.2024.02.001","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T08:33:45Z","timestamp":1712565225000},"page":"143-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Cardiovascular Concerns, Cancer Treatment, and Biological and Chronological Aging in Cancer"],"prefix":"10.1016","volume":"6","author":[{"given":"Dina","family":"Ioffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjana C.","family":"Bhatia-Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman A.","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrat","family":"Dotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccao.2024.02.001_bib1","series-title":"Mortality in the United States, 2021. NCHS Data Brief No. 456","author":"Xu","year":"2022"},{"issue":"10","key":"10.1016\/j.jaccao.2024.02.001_bib2","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics\u20142019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jaccao.2024.02.001_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ijc.31664","article-title":"Global cancer incidence in older adults, 2012 and 2035: a population-based study","volume":"144","author":"Pilleron","year":"2019","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.jaccao.2024.02.001_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.jaccao.2024.02.001_bib5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3322\/caac.21731","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.jaccao.2024.02.001_bib6","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jacc.2019.06.053","article-title":"Cardiovascular aging and heart failure: JACC review topic of the week","volume":"74","author":"Triposkiadis","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.jaccao.2024.02.001_bib7","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases","volume":"14","author":"Franceschi","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"10.1016\/j.jaccao.2024.02.001_bib8","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jaccao.2024.02.001_bib9","doi-asserted-by":"crossref","first-page":"628","DOI":"10.14336\/AD.2017.0103","article-title":"The biology of aging and cancer: a brief overview of shared and divergent molecular hallmarks","volume":"8","author":"Aunan","year":"2017","journal-title":"Aging Dis"},{"issue":"11","key":"10.1016\/j.jaccao.2024.02.001_bib10","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41569-023-00881-3","article-title":"Hallmarks of cardiovascular ageing","volume":"20","author":"Abdellatif","year":"2023","journal-title":"Nat Rev Cardiol"},{"issue":"16","key":"10.1016\/j.jaccao.2024.02.001_bib11","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.3390\/ijms21165598","article-title":"The Significance of mitochondrial dysfunction in cancer","volume":"21","author":"Luo","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.jaccao.2024.02.001_bib12","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/gerona\/glac247","article-title":"The aging\u2013cancer cycle: mechanisms and opportunities for intervention","volume":"78","author":"Sedrak Mina","year":"2022","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"issue":"8","key":"10.1016\/j.jaccao.2024.02.001_bib13","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1634\/theoncologist.2010-0348","article-title":"Cardiovascular complications of breast cancer therapy in older adults","volume":"16","author":"Shenoy","year":"2011","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.jaccao.2024.02.001_bib14","first-page":"431","article-title":"Risk of cancer after diagnosis of cardiovascular disease","volume":"5","author":"Bell","year":"2023","journal-title":"J\u00a0Am Coll Cardiol CardioOnc"},{"issue":"48","key":"10.1016\/j.jaccao.2024.02.001_bib15","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","article-title":"A\u00a0population-based study of cardiovascular disease mortality risk in US cancer patients","volume":"40","author":"Sturgeon","year":"2019","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.jaccao.2024.02.001_bib16","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1200\/JCO.2015.64.0409","article-title":"Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study","volume":"34","author":"Armenian","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.jaccao.2024.02.001_bib17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3322\/caac.21638","article-title":"Older adult participation in cancer clinical trials: a systematic review of barriers and interventions","volume":"71","author":"Sedrak","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.jaccao.2024.02.001_bib18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jgo.2019.12.007","article-title":"The underreporting of phase III chemo-therapeutic clinical trial data of older patients with cancer: a systematic review","volume":"11","author":"BrintzenhofeSzoc","year":"2020","journal-title":"J\u00a0Geriatr Oncol"},{"issue":"60","key":"10.1016\/j.jaccao.2024.02.001_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jncimonographs\/lgac023","article-title":"Trial design considerations to increase older adult accrual to National Cancer Institute clinical trials","volume":"2022","author":"Le-Rademacher","year":"2022","journal-title":"J\u00a0Natl Cancer Inst Monogr"},{"issue":"15_suppl","key":"10.1016\/j.jaccao.2024.02.001_bib20","article-title":"Patient-defined goals and preferences among older adults with cancer starting chemotherapy (CT)","volume":"36","author":"Celis","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2024.02.001_bib21","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2147\/CIA.S57849","article-title":"Optimal management of elderly cancer patients: usefulness of the Comprehensive Geriatric Assessment","volume":"9","author":"Paillaud","year":"2014","journal-title":"Clin Interv Aging"},{"issue":"25","key":"10.1016\/j.jaccao.2024.02.001_bib22","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","article-title":"Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study","volume":"29","author":"Hurria","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.jaccao.2024.02.001_bib23","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1080\/0284186X.2016.1219047","article-title":"Physical performance measures for predicting outcome in cancer patients: a systematic review","volume":"55","author":"Verweij","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jaccao.2024.02.001_bib24","article-title":"NCCN Guidelines\u00ae insights: older adult oncology, version 1.2023","author":"Dotan","year":"2023","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"26","key":"10.1016\/j.jaccao.2024.02.001_bib25","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.23.00933","article-title":"Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update","volume":"41","author":"Dale","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.jaccao.2024.02.001_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jgo.2015.12.002","article-title":"Comorbidity in older adults with cancer","volume":"7","author":"Williams","year":"2016","journal-title":"J\u00a0Geriatr Oncol"},{"issue":"2","key":"10.1016\/j.jaccao.2024.02.001_bib27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jgo.2015.12.003","article-title":"Comparing comorbidity scales: attending physician score versus the Cumulative Illness Rating Scale for Geriatrics","volume":"7","author":"Kirkhus","year":"2016","journal-title":"J\u00a0Geriatr Oncol"},{"issue":"1","key":"10.1016\/j.jaccao.2024.02.001_bib28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1200\/JCO.2010.31.3049","article-title":"Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review","volume":"29","author":"Lee","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.jaccao.2024.02.001_bib29","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.3390\/cancers14092236","article-title":"The prognostic value of eight comorbidity indices in older patients with cancer: the ELCAPA cohort study","volume":"14","author":"Canoui-Poitrine","year":"2022","journal-title":"Cancers"},{"issue":"19","key":"10.1016\/j.jaccao.2024.02.001_bib30","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1200\/JCO.21.00239","article-title":"Cognitive function in older adults with cancer: assessment, management, and research opportunities","volume":"39","author":"Magnuson","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2024.02.001_bib31","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1200\/EDBK_237641","article-title":"A\u00a0practical guide to geriatric syndromes in older adults with cancer: a focus on falls, cognition, polypharmacy, and depression","volume":"39","author":"Magnuson","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"5","key":"10.1016\/j.jaccao.2024.02.001_bib32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jgo.2016.07.010","article-title":"Polypharmacy and potentially inappropriate medication use in geriatric oncology","volume":"7","author":"Sharma","year":"2016","journal-title":"J\u00a0Geriatr Oncol"},{"issue":"1","key":"10.1016\/j.jaccao.2024.02.001_bib33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jgo.2020.06.013","article-title":"Identifying potentially inappropriate medication (PIM) use in geriatric oncology","volume":"12","author":"Miller","year":"2021","journal-title":"J\u00a0Geriatr Oncol"},{"issue":"4","key":"10.1016\/j.jaccao.2024.02.001_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jgo.2016.04.006","article-title":"Gaps in nutritional research among older adults with cancer","volume":"7","author":"Presley","year":"2016","journal-title":"J\u00a0Geriatr Oncol"},{"issue":"3","key":"10.1016\/j.jaccao.2024.02.001_bib35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3390\/nu13030761","article-title":"Sarcopenia, malnutrition, and cachexia: adapting definitions and terminology of nutritional disorders in older people with cancer","volume":"13","author":"Meza-Valderrama","year":"2021","journal-title":"Nutrients"},{"issue":"32","key":"10.1016\/j.jaccao.2024.02.001_bib36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.14694\/EdBook_AM.2012.32.168","article-title":"Considerations and controversies in the management of older patients with advanced cancer","author":"Mohile","year":"2012","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.jaccao.2024.02.001_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/1534735419881498","article-title":"The effects of dosage-controlled cannabis capsules on cancer-related cachexia and anorexia syndrome in advanced cancer patients: pilot study","volume":"18","author":"Bar-Sela","year":"2019","journal-title":"Integr Cancer Ther"},{"issue":"3","key":"10.1016\/j.jaccao.2024.02.001_bib38","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1634\/theoncologist.5-3-224","article-title":"Management of cancer in the older person: a practical approach","volume":"5","author":"Balducci","year":"2000","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.jaccao.2024.02.001_bib39","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1007\/s00520-013-1897-1","article-title":"Cancer-related fatigue in the elderly","volume":"21","author":"Giacalone","year":"2013","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.jaccao.2024.02.001_bib40","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","article-title":"The timed \u201cup & go\u201d: a test of basic functional mobility for frail elderly persons","volume":"39","author":"Podsiadlo","year":"1991","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"26","key":"10.1016\/j.jaccao.2024.02.001_bib41","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1200\/JCO.2008.19.9463","article-title":"Distress in older patients with cancer","volume":"27","author":"Hurria","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.jaccao.2024.02.001_bib42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/pon.3886","article-title":"Geriatric assessment findings independently associated with clinical depression in 1092 older patients with cancer: the ELCAPA cohort study","volume":"25","author":"Canoui-Poitrine","year":"2016","journal-title":"Psychooncology"},{"issue":"29","key":"10.1016\/j.jaccao.2024.02.001_bib43","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1200\/JCO.2006.10.0438","article-title":"Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders","volume":"25","author":"Mitchell","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2024.02.001_bib44","first-page":"CD006211","article-title":"Comprehensive geriatric assessment for older adults admitted to hospital","volume":"9","author":"Ellis","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.jaccao.2024.02.001_bib45","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.6004\/jnccn.2015.0137","article-title":"Geriatric assessment\u2013guided care processes for older adults: a Delphi consensus of geriatric oncology experts","volume":"13","author":"Mohile","year":"2015","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"6","key":"10.1016\/j.jaccao.2024.02.001_bib46","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jgo.2022.04.008","article-title":"Geriatric assessment in the management of older patients with cancer\u2014a systematic review (update)","volume":"13","author":"Hamaker","year":"2022","journal-title":"J\u00a0Geriatr Oncol"},{"issue":"6","key":"10.1016\/j.jaccao.2024.02.001_bib47","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1200\/OP.20.00442","article-title":"How is geriatric assessment used in clinical practice for older adults with cancer? A survey of cancer providers by the American Society of Clinical Oncology","volume":"17","author":"Dale","year":"2021","journal-title":"JCO Oncol Pract"},{"issue":"8","key":"10.1016\/j.jaccao.2024.02.001_bib48","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/annonc\/mdr587","article-title":"Screening older cancer patients: first evaluation of the G-8 geriatric screening tool","volume":"23","author":"Bellera","year":"2012","journal-title":"Ann Oncol"},{"issue":"13","key":"10.1016\/j.jaccao.2024.02.001_bib49","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/cncr.26646","article-title":"Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score","volume":"118","author":"Extermann","year":"2012","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.jaccao.2024.02.001_bib50","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.critrevonc.2010.08.004","article-title":"Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients","volume":"79","author":"Chaibi","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"10.1016\/j.jaccao.2024.02.001_bib51","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/bjc.2015.120","article-title":"The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people","volume":"112","author":"Kalsi","year":"2015","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.jaccao.2024.02.001_bib52","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.4158","article-title":"Geriatric Assessment-Driven Intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial","volume":"7","author":"Li","year":"2021","journal-title":"JAMA Oncol"},{"issue":"10314","key":"10.1016\/j.jaccao.2024.02.001_bib53","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(21)01789-X","article-title":"Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study","volume":"398","author":"Mohile","year":"2021","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.jaccao.2024.02.001_bib54","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1200\/JCO.2018.78.8687","article-title":"Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology","volume":"36","author":"Mohile","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.jaccao.2024.02.001_bib55","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1200\/JCO.20.02063","article-title":"Development and validation of a risk tool for predicting severe toxicity in older adults receiving chemotherapy for early-stage breast cancer","volume":"39","author":"Magnuson","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.jaccao.2024.02.001_bib56","article-title":"Risk prediction model for heart failure and cardiomyopathy after adjuvant trastuzumab therapy for breast cancer","volume":"3","author":"Ezaz","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.jaccao.2024.02.001_bib57","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3324\/haematol.2021.278802","article-title":"Randomized controlled trial of geriatric consultation versus standard care in older adults with hematologic malignancies","volume":"107","author":"Dumontier","year":"2021","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.jaccao.2024.02.001_bib58","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/jamaoncol.2019.4728","article-title":"Communication with older patients with cancer using geriatric assessment","volume":"6","author":"Mohile","year":"2020","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.jaccao.2024.02.001_bib59","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jacc.2021.11.029","article-title":"Interventions for frailty among older adults with cardiovascular disease","volume":"79","author":"Ijaz","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jaccao.2024.02.001_bib60","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","article-title":"Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations","volume":"31","author":"Curigliano","year":"2020","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.jaccao.2024.02.001_bib61","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/ejhf.2017","article-title":"Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart\u00a0Failure Association and the Cardio-Oncology Council of the European Society of Cardiology","volume":"22","author":"Pudil","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10.1016\/j.jaccao.2024.02.001_bib62","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/ejhf.1957","volume":"22","author":"\u010celutkien\u0117","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"41","key":"10.1016\/j.jaccao.2024.02.001_bib63","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jaccao.2024.02.001_bib64","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1182\/bloodadvances.2019000955","article-title":"Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia: a Young SIOG review paper","volume":"4","author":"Neuendorff","year":"2020","journal-title":"Blood Adv"},{"issue":"22","key":"10.1016\/j.jaccao.2024.02.001_bib65","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.jacc.2019.03.495","article-title":"Randomized trial of lisinopril versus carvedilol to prevent trastuzumab cardiotoxicity in patients with breast cancer","volume":"73","author":"Guglin","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jaccao.2024.02.001_bib66","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10549-019-05191-2","article-title":"Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study","volume":"175","author":"Lynce","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"19","key":"10.1016\/j.jaccao.2024.02.001_bib67","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1200\/JCO.22.01016","article-title":"Cardiovascular disease in testicular cancer survivors: identification of risk factors and impact on quality of life","volume":"41","author":"Lubberts","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"issue":"16","key":"10.1016\/j.jaccao.2024.02.001_bib68","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/jama.2022.4983","article-title":"Aspirin use to prevent cardiovascular disease","volume":"327","author":"Davidson","year":"2022","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.jaccao.2024.02.001_bib69","doi-asserted-by":"crossref","first-page":"792","DOI":"10.6004\/jnccn.2023.0041","article-title":"NCCN Guidelines\u00ae insights: survivorship, version 1.2023","volume":"21","author":"Sanft","year":"2023","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"4","key":"10.1016\/j.jaccao.2024.02.001_bib70","first-page":"661","article-title":"How to follow, manage and treat cardiac dysfunction in patients with HER2+ breast cancer","volume":"2","author":"Blaes","year":"2020","journal-title":"J\u00a0Am Coll Cardiol CardioOnc"},{"issue":"3","key":"10.1016\/j.jaccao.2024.02.001_bib71","article-title":"Geriatric cardiology: coming of age","volume":"1","author":"Goyal","year":"2022","journal-title":"JACC Adv"},{"issue":"21","key":"10.1016\/j.jaccao.2024.02.001_bib72","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","article-title":"Emergency hospitalizations for adverse drug events in older Americans","volume":"365","author":"Budnitz","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.jaccao.2024.02.001_bib73","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.006977","article-title":"Polypharmacy in older adults hospitalized for heart failure","volume":"13","author":"Unlu","year":"2020","journal-title":"Circ Heart Fail"},{"issue":"20","key":"10.1016\/j.jaccao.2024.02.001_bib74","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1001\/jama.2020.4871","article-title":"Effect of antihypertensive medication reduction vs usual care on short-term blood pressure control in patients with hypertension aged 80 years and older","volume":"323","author":"Sheppard","year":"2020","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.jaccao.2024.02.001_bib75","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1002\/cncr.24621","article-title":"Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast cancer","volume":"115","author":"Du","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jaccao.2024.02.001_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.645026","article-title":"Long-term cardiac safety and survival outcomes of neoadjuvant pegylated liposomal doxorubicin in elderly patients or prone to cardiotoxicity and triple negative breast cancer. Final results of the multicentre phase II CAPRICE study","volume":"11","author":"Gil-Gil","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jaccao.2024.02.001_bib77","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.breast.2016.11.006","article-title":"Cardiac safety of adjuvant non-pegylated liposomal doxorubicin combined with cyclophosphamide and followed by paclitaxel in older breast cancer patients","volume":"31","author":"Coltelli","year":"2017","journal-title":"Breast"},{"issue":"8","key":"10.1016\/j.jaccao.2024.02.001_bib78","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ctrv.2013.03.005","article-title":"Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors","volume":"39","author":"Polk","year":"2013","journal-title":"Cancer Treat Rev"},{"issue":"11","key":"10.1016\/j.jaccao.2024.02.001_bib79","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S1470-2045(13)70154-2","article-title":"Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial","volume":"14","author":"Cunningham","year":"2013","journal-title":"Lancet Oncol"},{"issue":"34","key":"10.1016\/j.jaccao.2024.02.001_bib80","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1200\/JCO.23.00506","article-title":"Initial panitumumab plus FOLFOX or 5-FU\/LV in elderly patients with RAS and BRAF wild-type metastatic colorectal cancer: the PANDA trial by GONO foundation","volume":"41","author":"Lonardi","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.jaccao.2024.02.001_bib81","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1634\/theoncologist.2016-0462","article-title":"Geriatric assessment predicts survival and competing mortality in elderly patients with early colorectal cancer: can it help in adjuvant therapy decision-making?","volume":"22","author":"Antonio","year":"2017","journal-title":"Oncologist"},{"issue":"12","key":"10.1016\/j.jaccao.2024.02.001_bib82","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/s41416-021-01367-0","article-title":"The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO)","volume":"124","author":"Lund","year":"2021","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.jaccao.2024.02.001_bib83","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1200\/JCO.2015.61.8413","article-title":"Long-term cardiac safety analysis of NCCTG N9831 (Alliance) adjuvant trastuzumab trial","volume":"34","author":"Advani","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.jaccao.2024.02.001_bib84","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(19)30863-0","article-title":"Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study","volume":"21","author":"Swain","year":"2020","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.jaccao.2024.02.001_bib85","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10549-013-2710-z","article-title":"Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)","volume":"142","author":"Miles","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"15_suppl","key":"10.1016\/j.jaccao.2024.02.001_bib86","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2015.33.15_suppl.603","article-title":"Safety of trastuzumab emtansine (T-DM1) in 373 patients 65 years or older with HER2-positive advanced breast cancer: a subgroup analysis of the Kamilla study","volume":"33","author":"Barrios","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.jaccao.2024.02.001_bib87","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMoa2115022","article-title":"Trastuzumab deruxtecan versus trastuzumab emtansine for breast cancer","volume":"386","author":"Cort\u00e9s","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.jaccao.2024.02.001_bib88","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2203690","article-title":"Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer","volume":"387","author":"Modi","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.jaccao.2024.02.001_bib89","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tcm.2012.09.008","article-title":"Cardiovascular complications associated with novel angiogenesis inhibitors: emerging evidence and evolving perspectives","volume":"23","author":"Bair","year":"2013","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.jaccao.2024.02.001_bib90","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jgo.2013.08.006","article-title":"Bevacizumab in elderly patients with metastatic colorectal cancer","volume":"5","author":"Sclafani","year":"2014","journal-title":"J\u00a0Geriatr Oncol"},{"issue":"1","key":"10.1016\/j.jaccao.2024.02.001_bib91","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.3802\/jgo.2020.31.e6","article-title":"Tolerability of bevacizumab in elderly ovarian cancer patients (TURBO study): a case-control study of a real-life experience","volume":"31","author":"Amadio","year":"2020","journal-title":"J\u00a0Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.jaccao.2024.02.001_bib92","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1903307","article-title":"Apalutamide for metastatic, castration-sensitive prostate cancer","volume":"381","author":"Chi","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.jaccao.2024.02.001_bib93","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1056\/NEJMoa1815671","article-title":"Darolutamide in nonmetastatic, castration-resistant prostate cancer","volume":"380","author":"Fizazi","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.jaccao.2024.02.001_bib94","doi-asserted-by":"crossref","first-page":"e645","DOI":"10.1016\/j.clgc.2017.12.007","article-title":"The cardiovascular toxicity of abiraterone and enzalutamide in prostate cancer","volume":"16","author":"Iacovelli","year":"2018","journal-title":"Clin Genitourin Cancer"},{"issue":"7","key":"10.1016\/j.jaccao.2024.02.001_bib95","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.119.044750","article-title":"Aromatase inhibitors and the risk of cardiovascular outcomes in women with breast cancer","volume":"141","author":"Khosrow-Khavar","year":"2020","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jaccao.2024.02.001_bib96","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.jaccao.2024.02.001_bib97","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2207586","article-title":"Breast-conserving surgery with or without irradiation in early breast cancer","volume":"388","author":"Kunkler","year":"2023","journal-title":"N\u00a0Engl J Med"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087324000541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087324000541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T19:21:48Z","timestamp":1734549708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666087324000541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":97,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2666087324000541"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2024.02.001","relation":{},"ISSN":["2666-0873"],"issn-type":[{"value":"2666-0873","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Concerns, Cancer Treatment, and Biological and Chronological Aging in Cancer","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2024.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}